{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:29:25Z","timestamp":1782959365119,"version":"3.54.5"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7889","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T22:09:48Z","timestamp":1498860588000},"page":"1729-1732","source":"Crossref","is-referenced-by-count":4,"title":["Neuromyelitis Optica Spectrum Disorder with Recurrent Intracranial Hemorrhage"],"prefix":"10.2169","volume":"56","author":[{"given":"Hiroaki","family":"Yaguchi","sequence":"first","affiliation":[{"name":"Department of Neurology, Brain Science Center, Sapporo City General Hospital, Japan"},{"name":"Department of Neurology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Mito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Science Center, Sapporo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikkei","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Science Center, Sapporo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Science Center, Sapporo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Science Center, Sapporo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112, 2004.","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 80: 2210-2216, 2013.","DOI":"10.1212\/WNL.0b013e318296ea08"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85: 177-189, 2015.","DOI":"10.1212\/WNL.0000000000001729"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimizu F, Sano Y, Takahashi T, et al. Sera from neuromyelitis optica patients disrupt the blood-brain barrier. J Neurol Neurosurg Psychiatry 83: 288-297, 2012.","DOI":"10.1136\/jnnp-2011-300434"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Uzawa A, Mori M, Masuda S, Kuwabara S. Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica. Arch Neurol 68: 913-917, 2011.","DOI":"10.1001\/archneurol.2011.148"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vincent T, Saikali P, Cayrol R, et al. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol 181: 5730-5737, 2008.","DOI":"10.4049\/jimmunol.181.8.5730"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 66: 425-428, 2009.","DOI":"10.1002\/ana.21753"},{"key":"8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ncn3.68","volume":"2","author":"S Shirai","year":"2014","unstructured":"8. Shirai S, Mito Y, Nojo T, et al. Neuromyelitis optica spectrum disorders accompanying subarachnoid hemorrhage and reversible white matter lesions. Neurology and Clinical Neuroscience 2: 10-12, 2014.","journal-title":"Neurology and Clinical Neuroscience","ISSN":"https:\/\/id.crossref.org\/issn\/2049-4173","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55: 250-256, 2004.","DOI":"10.1002\/ana.10810"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Moftakhar P, Lynch MD, Pomakian JL, Vinters HV. Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy. J Neuropathol Exp Neurol 69: 1201-1209, 2010.","DOI":"10.1097\/NEN.0b013e3181fd252c"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology 68 (16 Suppl 2): S23-S36, 2007.","DOI":"10.1212\/01.wnl.0000259404.51352.7f"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Robinson CA, Adiele RC, Tham M, Lucchinetti CF, Popescu BF. Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis. Acta Neuropathol Commun 2: 52, 2014.","DOI":"10.1186\/2051-5960-2-52"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Keep RF, Zhou N, Xiang J, Andjelkovic AV, Hua Y, Xi G. Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage. Fluids Barriers CNS 11: 18, 2014.","DOI":"10.1186\/2045-8118-11-18"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/13\/56_56.7889\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T02:37:35Z","timestamp":1569638255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/13\/56_56.7889\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":13,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7889","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}